PRODH and cancer: Although the complex regulatory mechanisms driving PRODH/POX-dependent functions are not well understood, in general, the above data suggest that inhibition of collagen biosynthesis in cancer cells contributes to increase in PRODH/POX-induced apoptosis and the process (collagen biosynthesis) could be considered a target for cancer treatment.